Carman Alenson - Net Worth and Insider Trading
Carman Alenson Net Worth
The estimated net worth of Carman Alenson is at least $0 dollars as of 2024-11-13. Carman Alenson is the Principal Accounting Officer of Agios Pharmaceuticals Inc and owns about 0 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $0. Details can be seen in Carman Alenson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carman Alenson has not made any transactions after 2021-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carman Alenson
Carman Alenson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carman Alenson owns 2 companies in total, including Agios Pharmaceuticals Inc (AGIO) , and Prime Medicine Inc (PRME) .
Click here to see the complete history of Carman Alenson’s form 4 insider trades.
Insider Ownership Summary of Carman Alenson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2021-06-21 | Principal Accounting Officer |
| PRME | Prime Medicine Inc | 2022-10-19 | See Remarks |
Carman Alenson Latest Holdings Summary
Carman Alenson currently owns a total of 1 stock. Carman Alenson owns 0 shares of Agios Pharmaceuticals Inc (AGIO) as of June 21, 2021, with a value of $0.
Latest Holdings of Carman Alenson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2021-06-21 | 0 | 59.02 | 0 |
Holding Weightings of Carman Alenson
Carman Alenson Form 4 Trading Tracker
According to the SEC Form 4 filings, Carman Alenson has made a total of 7 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 1,777 shares on June 21, 2021, which brought Carman Alenson around $109,481.
Insider Trading History of Carman Alenson
- 1
Carman Alenson Trading Performance
Carman Alenson Ownership Network
Ownership Network List of Carman Alenson
Ownership Network Relation of Carman Alenson
Carman Alenson Owned Company Details
What does Agios Pharmaceuticals Inc do?
Who are the key executives at Agios Pharmaceuticals Inc?
Carman Alenson is the Principal Accounting Officer of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include Chief Financial Officer Cecilia Jones , director & Chief Executive Officer Brian Goff , and Chief Medical Officer Sarah Gheuens .
Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary
Over the past 18 months, Carman Alenson made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 9,416 shares made by Washburn Theodore James Jr. , a net sale of 64,534 shares made by Brian Goff , and a net sale of 14,160 shares made by James William Burns .
In summary, during the past 3 months, insiders sold 2,542 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 2,542 shares. During the past 18 months, 252,596 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 252,596 shares.
Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agios Pharmaceuticals Inc Insider Transactions
Carman Alenson Mailing Address
Above is the net worth, insider trading, and ownership report for Carman Alenson. You might contact Carman Alenson via mailing address: 88 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
